U.S. Professional Services Stock News

NasdaqGS:CHA
NasdaqGS:CHAHospitality

Chagee Holdings (CHA) Margin Slide Challenges Bullish Growth Narrative After Q1 2026 Results

Chagee Holdings (NasdaqGS:CHA) opened Q1 2026 with revenue of C¥3.5b and basic EPS of C¥2.36, alongside net income excluding extra items of C¥450.33m, as the stock trades around $12.76. The company has seen quarterly revenue move from C¥3.39b in Q1 2025 to C¥3.55b in Q1 2026, while basic EPS shifted from C¥6.58 to C¥2.36 over the same period. This sets up a picture where topline scale is paired with changing per share profitability. For investors, a key consideration is how to weigh that...
NYSE:HPQ
NYSE:HPQTech

Has The Recent Rally Left HP (HPQ) Fully Priced Or Is Value Still On Offer?

Wondering if HP at US$27.04 is offering good value right now, or if the recent excitement has already been priced in? The stock has returned 7.1% over the past week, 29.8% over the past month, 22.2% year to date, and 14.1% over the past year. The 3 year return is roughly flat and the 5 year return stands at 5.6%. Recent headlines around PC demand, printing markets, and broader tech sector sentiment have kept HP on many investors' watchlists. Together, these themes help frame how the market...
NYSE:RBLX
NYSE:RBLXEntertainment

Is Roblox (RBLX) Starting To Look Attractive After A 42% Year To Date Share Price Fall

If you are wondering whether Roblox at US$47.15 is starting to look like value or still carries a valuation premium, it helps to line up the recent share performance with what the fundamentals suggest. The stock has fallen 41.8% year to date and is down 45.8% over the last 12 months, although it has gained 4.5% over the last 30 days and declined 2.1% in the past week, which can change how investors think about both upside potential and risk. Recent news coverage has focused on Roblox as a...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Agios Halts Tebapivat Trials As Sickle Cell Focus Shapes Valuation

Agios Pharmaceuticals halted development of tebapivat in lower risk myelodysplastic syndromes after a Phase 2b trial did not meet internal efficacy thresholds. The decision removes a candidate from Agios’s rare blood disorder pipeline and follows a review of trial data against the company’s internal benchmarks. Agios plans to continue concentrating resources on its sickle cell disease program and broader portfolio in rare hematologic conditions. For investors tracking NasdaqGS:AGIO, the...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen’s Alkira Deal Shifts Focus Toward Cloud Growth And Valuation Risk

Lumen Technologies (NYSE:LUMN) announced the acquisition of Alkira, a cloud-native networking platform provider. The transaction is intended to accelerate Lumen's digital platform strategy and expand its cloud and networking capabilities. The deal marks a shift in focus toward growth initiatives beyond Lumen's legacy telecom services. Lumen Technologies operates as a communications and digital infrastructure company, and this move directs more of its focus toward cloud networking and...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Is It Too Late To Consider Gen Digital (GEN) After Its Sharp Monthly Rally?

Deciding whether Gen Digital stock still offers value at its current level, or if the easy gains are behind it, starts with understanding what the recent price action is really telling you. The stock recently closed at US$25.79, with the share price up 3.9% over the past week and 33.1% over the past month, even though the return over the past year is down 7.7% and the year-to-date return is down 1.1%. Recent coverage has focused on how Gen Digital fits into broader software sector themes and...
NYSE:COLD
NYSE:COLDIndustrial REITs

Is Americold (COLD) Using Its New Cost Cuts To Redefine Its Cold-Chain Investment Story?

Earlier in May 2026, Americold Realty Trust launched its “Fit for Purpose” initiative to streamline overhead, targeting more than US$25.00 million in annual cost savings by the end of the first quarter of 2027. This push to cut expenses builds on earlier cost-reduction programs and could meaningfully affect how investors view Americold’s efficiency and earnings potential. Next, we’ll examine how Americold’s Fit for Purpose cost-savings drive may influence its investment narrative built...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Digital’s Bitcoin Exit Tests Timing Of AI Data Center Ramp

Cipher Digital (NasdaqGS:CIFR) is confronting a timing gap as legacy bitcoin mining revenue winds down faster than new data center leases scale up. Recent SEC filings show hedge fund manager Leopold Aschenbrenner has exited his position, highlighting concerns about this transition risk. The company has secured over $9b in long term hyperscale leases with customers such as AWS and Google, tying its outlook closely to AI and high performance computing demand. This operational gap and related...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

AM Best Rating Reaffirmation Supports Popular Valuation Case For Investors

AM Best affirmed the financial strength and issuer credit ratings of Popular Life Re, a subsidiary of Popular, Inc., with a stable outlook. The decision reflects AM Best’s view of Popular Life Re’s capital position and risk management profile. This ratings affirmation is relevant for investors tracking Popular’s insurance operations under ticker NasdaqGS:BPOP. For Popular, which trades on NasdaqGS:BPOP, this ratings affirmation comes as the stock changes hands at $148.53. The company has...
NYSE:EARN
NYSE:EARNCapital Markets

Ellington Credit (EARN) TTM Loss Of US$38.9 Million Challenges High Yield Bull Case

Ellington Credit (EARN) just wrapped up FY 2026 with Q4 total revenue of US$10.0 million and basic EPS of US$0.86 loss, while the trailing twelve months show total revenue of US$43.5 million and basic EPS of US$1.03 loss. Over recent periods, the company has seen quarterly revenue move between US$9.98 million and US$29.0 million, with basic EPS ranging from a profit of about US$0.19 to a loss of roughly US$0.86, giving a mixed read on earnings quality and payout capacity. For investors, that...